                         SEQUENCE LISTING

<110>  The University of Sydney, Western Sydney Local Health District
 
<120>  Connexin 45 Inhibition for Therapy

<130>  174211

<150>  AU2015903282
<151>  2015-08-14

<160>  27    

<170>  PatentIn version 3.5

<210>  1
<211>  1191
<212>  RNA
<213>  Homo sapiens

<400>  1
augaguugga gcuuucugac ucgccugcua gaggagauuc acaaccauuc cacauuugug       60

gggaagaucu ggcucacugu ucugauuguc uuccggaucg uccuuacagc uguaggagga      120

gaauccaucu auuacgauga gcaaagcaaa uuugugugca acacagaaca gccgggcugu      180
a
gagaaugucu guuaugaugc guuugcaccu cucucccaug uacgcuucug gguguuccag      240

aucauccugg uggcaacucc cucugugaug uaccugggcu augcuaucca caagauugcc      300

aaaauggagc acggugaagc agacaagaag gcagcucgga gcaagcccua ugcaaugcgc      360

uggaaacaac accgggcucu ggaagaaacg gaggaggaca acgaagagga uccuaugaug      420

uauccagaga uggaguuaga aagugauaag gaaaauaaag agcagagcca acccaaaccu      480

aagcaugaug gccgacgacg gauucgggaa gaugggcuca ugaaaaucua ugugcugcag      540

uugcuggcaa ggaccguguu ugaggugggu uuucugauag ggcaguauuu ucuguauggc      600

uuccaagucc acccguuuua ugugugcagc agacuuccuu guccucauaa gauagacugc      660

uuuauuucua gacccacuga aaagaccauc uuccuucuga uaauguaugg uguuacaggc      720

cuuugccucu ugcuuaacau uugggagaug cuucauuuag gguuugggac cauucgagac      780

ucacuaaaca guaaaaggag ggaacuugag gauccgggug cuuauaauua uccuuucacu      840

uggaauacac caucugcucc cccuggcuau aacauugcug ucaaaccaga ucaaauccag      900

uacaccgaac uguccaaugc uaagaucgcc uacaagcaaa acaaggccaa cacagcccag      960

gaacagcagu auggcagcca ugaggagaac cucccagcug accuggaggc ucugcagcgg     1020

gagaucagga uggcucagga acgcuuggau cuggcaguuc aggccuacag ucaccaaaac     1080

aacccucaug guccccggga gaagaaggcc aaaguggggu ccaaagcugg guccaacaaa     1140

agcacugcca guagcaaauc aggggauggg aagaacucug ucuggauuua a              1191


<210>  2
<211>  1599
<212>  RNA
<213>  Rattus Norvegicus

<400>  2
uuguucuucg uugacucucc agauugaaaa uagagaggag gcgcuaaugc ugugauuggg       60

cuggcugcug cguuuggauu uucgaguuga aaagauuuac gugacuugug uuuagaauuu      120

gggguccuuc cuccccgcuu uucggauuau uugggauugc uuuucuuuuu gcgaaguggg      180

ugaauuuguu uuuuuuuuuu uugucauuug aagucauuuu ugguccucgg ggacuggcag      240

cgcuacagau uucauugugc ucgugcuuua uuuuuuuucu cauccacacu gggugccauc      300

gaggaacuca agagagaauu ugggaaagua acaaacacag cacagaaucu gaaaggaggu      360

uuuggguaac ggagguucug guuaacaggg caaaccaauu ccaccaccau gaguuggagc      420

uuccugacuc gccugcuaga ggagauacac aaccauucga cguuuguagg gaagaucugg      480

cucacugugc ugauugucuu ucgaauuguc cuaacugcgg uaggaggaga guccaucuac      540

uaugaugagc aaagcaaauu ugugugcaac acagagcagc cgggcuguga gaacgucugc      600

uaugaugccu uugccccgcu cucccacgug cgcuucuggg uauuccagau cauccugguu      660

gcuacucccu cggugaugua ccugggauau gcuauucaca agauugccaa aauggagcac      720

ggcgaggcag acaagaaggc agcucggagc aaacccuaug ccaugcguug gaagcagcac      780

cgggcucugg aagaaacgga agaggaccau gaagaggauc cuaugaugua cccagagaug      840

gaguuagaaa gcgagaaaga aaauaaagag cagagccaac caaaacccaa gcaugauggc      900

cgccgacgca uucgugagga ugggcucaug aaaaucuaug uguugcagcu gcuagccagg      960

acuguguuug aggugggcuu ucucauaggg caguauuucc uguauggcuu ccaaguacac     1020

ccauuuuaug ugugcagcag acuuccuugu ccucauaaga uagacugcuu uauuucuaga     1080

cccacugaaa agaccaucuu ccuucugaua auguauggug ucacaggccu cugccuauug     1140

cuuaacauuu gggagaugcu ucaucuaggg uuugggacca uucgagacuc acuaaacagu     1200

aaaaggaggg aacuugauga uccgggugcu uauaauuauc cuuucacuug gaauacacca     1260

ucugcucccc caggcuauaa cauugcuguc aaaccagauc aaauccagua cacugaguug     1320

uccaaugcua agauugccua caagcagaac aaagccaaua ucgcccagga gcagcaguau     1380

ggcagccacg aggagcaccu cccggccgau cuggagaccc ugcagcggga gaucagaaug     1440

gcccaggaac gcuuggaucu agcaauccag gccuaccauc accagaacaa cccccauggu     1500

ccucgggaaa agaaggccaa aguggggucc aaaucugggu ccaacaaaag caguauuagu     1560

agcaaaucag gagaugggaa gaccuccguc uggauuuaa                            1599


<210>  3
<211>  20
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  Cx45-shRNA#1 Target region

<400>  3
gcuauaacau ugcugucaaa                                                   20


<210>  4
<211>  67
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Cx45-shRNA#1 Forward oligonucleotide

<400>  4
gatccgctat aacattgctg tcaaattcaa gagatttgac agcaatgtta tagtttttgg       60

aattaat                                                                 67


<210>  5
<211>  61
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Cx45-shRNA#1 Reverse Oligonucleotide

<400>  5
taattccaaa aactataaca ttgctgtcaa atctcttgaa tttgacagca atgttatagc       60

g                                                                       61


<210>  6
<211>  20
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  Cx45-shRNA#2 Target region

<400>  6
gcggaagagg accaugaaga                                                   20


<210>  7
<211>  67
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Cx45-shRNA#2 Forward oligonucleotide

<400>  7
gatccgcgga agaggaccat gaagattcaa gagatcttca tggtcctctt ccgtttttgg       60

aattaat                                                                 67


<210>  8
<211>  61
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Cx45-shRNA#2 Reverse Oligonucleotide

<400>  8
taattccaaa aacggaagag gaccatgaag atctcttgaa tcttcatggt cctcttccgc       60

g                                                                       61


<210>  9
<211>  19
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  Cx45-shRNA#3 Target region

<400>  9
ggagggaacu ugaugaucc                                                    19


<210>  10
<211>  66
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Cx45-shRNA#3 Forward oligonucleotide

<400>  10
gatccggagg gaacttgatg atccttcaag agaggatcat caagttccct cctttttgga       60

attaat                                                                  66


<210>  11
<211>  60
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Cx45-shRNA#3 Reverse Oligonucleotide

<400>  11
taattccaaa aaggagggaa cttgatgatc ctctcttgaa ggatcatcaa gttccctccg       60


<210>  12
<211>  19
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  Cx45-shRNA#4 Target region

<400>  12
agagcagagc caaccaaaa                                                    19


<210>  13
<211>  66
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Cx45-shRNA#4 Forward oligonucleotide

<400>  13
gatccagagc agagccaacc aaaattcaag agattttggt tggctctgct cttttttgga       60

attaat                                                                  66


<210>  14
<211>  60
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Cx45-shRNA#4 Reverse Oligonucleotide

<400>  14
taattccaaa aaagagcaga gccaaccaaa atctcttgaa ttttggttgg ctctgctctg       60


<210>  15
<211>  19
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  Cx45-shRNA#5 Target region

<400>  15
uaacauugcu gucaaacca                                                    19


<210>  16
<211>  67
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Cx45-shRNA#5 Forward oligonucleotide

<400>  16
gatccgtaac attgctgtca aaccattcaa gagatggttt gacagcaatg ttatttttgg       60

aattaat                                                                 67


<210>  17
<211>  61
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Cx45-shRNA#5 Reverse Oligonucleotide

<400>  17
taattccaaa aataacattg ctgtcaaacc atctcttgaa tggtttgaca gcaatgttac       60

g                                                                       61


<210>  18
<211>  19
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  Cx45-shRNA#6 Target region

<400>  18
gaccaucuuc cuucugaua                                                    19


<210>  19
<211>  66
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Cx45-shRNA#6 Forward oligonucleotide

<400>  19
gatccgacca tcttccttct gatattcaag agatatcaga aggaagatgg tctttttgga       60

attaat                                                                  66


<210>  20
<211>  60
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Cx45-shRNA#6 Reverse Oligonucleotide

<400>  20
taattccaaa aagaccatct tccttctgat atctcttgaa tatcagaagg aagatggtcg       60


<210>  21
<211>  19
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  Cx45-shRNA#7 Target region

<400>  21
gaggaccaug aagaggauc                                                    19


<210>  22
<211>  66
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Cx45-shRNA#7 Forward oligonucleotide

<400>  22
gatccgagga ccatgaagag gatcttcaag agagatcctc ttcatggtcc tctttttgga       60

attaat                                                                  66


<210>  23
<211>  60
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Cx45-shRNA#7 Reverse Oligonucleotide

<400>  23
taattccaaa aagaggacca tgaagaggat ctctcttgaa gatcctcttc atggtcctcg       60


<210>  24
<211>  19
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  Cx45-shRNA#8 Target region

<400>  24
gagaguccau cuacuauga                                                    19


<210>  25
<211>  66
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Cx45-shRNA#8 Forward oligonucleotide

<400>  25
gatccgagag tccatctact atgattcaag agatcatagt agatggactc tctttttgga       60

attaat                                                                  66


<210>  26
<211>  60
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Cx45-shRNA#8 Reverse Oligonucleotide

<400>  26
taattccaaa aagagagtcc atctactatg atctcttgaa tcatagtaga tggactctcg       60


<210>  27
<211>  9
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  Loop region

<400>  27
uucaagaga                                                                9
